Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04IQH
|
|||
| Former ID |
DNCL002965
|
|||
| Drug Name |
PF-655
|
|||
| Synonyms |
RTP801i14
Click to Show/Hide
|
|||
| Indication | Diabetic macular edema [ICD-11: 9B71.02] | Phase 2 | [1] | |
| Company |
Quark Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01445899) PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.